HINJ and BioNJ Commentary: Cost-Cutting Measures Could Stifle Biopharmaceutical Innovation in NJ
Cherry Hill, NJ, July 9, 2013 — The Courier-Post has published a commentary authored by Dean J. Paranicas, HealthCare Institute of New Jersey (HINJ) President